|AD Gilhart & Co||New York, New York, United States|
|BeiChen Venture Capital Management||Baoshan, China, Shanghai|
|Chenavari Investment Managers||England, London, United Kingdom|
|CSPC Pharmaceutical Group||China, Hebei, Shijiazhuang|
|ELAN Microelectronics||Hsinchu, Taiwan, Taiwan Province|
|Erfindungs Verwertung||Basel, Basel-Stadt, Switzerland|
|Flatiron Health||New York, New York, United States|
|GS Capital||China, Shanghai|
|Haima Touzi||China, Ningbo Shi, Zhejiang|
|Harris Blitzer Sports & Entertainment||Camden, New Jersey, United States|
|Origami Capital Partners||Chicago, Illinois, United States|
|Oriza Seed Capital (Oriza Yuandian)||China, Jiangsu, Suzhou|
|Psion||Canada, Mississauga, Ontario|
|SRF Partners Group||-|
|$7M||28 Apr 2022||Calgary, Canada|
|$3M||10 Sep 2021||Spain, Community of Madrid, Spain|
|$3M||01 Jan 2020||Spain, Community of Madrid, Spain|
|$900K||15 Oct 2019||La Union|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.